MHTT Insider Trading Activity and SEC Form 4 Filings
MHTT insider trading summary
No open-market insider purchases or sales of Manhattan Pharmaceuticals Inc (MHTT) have been reported on SEC Form 4 in the past 12 months.
Latest MHTT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 21, 2005 | Douglas Abel | President and CEO | Buy | $7K (5,000 @ $1.31) |
| Oct 20, 2005 | Douglas Abel | President and CEO | Buy | $6K (5,000 @ $1.29) |
| May 11, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $8K (5,000 @ $1.56) |
| May 9, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $8K (5,000 @ $1.50) |
| May 4, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $1K (1,000 @ $1.39) |
| May 4, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $3K (2,000 @ $1.40) |
| May 4, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $3K (2,000 @ $1.41) |
| May 3, 2005 | Lindsay A Md Rosenwald | 10% Owner | Buy | $7K (5,000 @ $1.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.